Vernal KeratoconjunctivitisSymptoms, Doctors, Treatments, Advances & More
Learn About Vernal Keratoconjunctivitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Baylor College Of Medicine - Ophthalmology
Stephen Pflugfelder, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Stephen Pflugfelder specializes in Ophthalmology (Eye) and works at BCM Ophthalmology. To make an appointment, please call (713) 798-6100. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Pflugfelder is rated as an Elite provider by MediFind in the treatment of Vernal Keratoconjunctivitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Dry Eye Syndrome, Giant Papillary Conjunctivitis, Conjunctivitis (Pink Eye), and Corneal Transplant. Dr. Pflugfelder is currently accepting new patients.
Andrea Leonardi practices practicing medicine in Padova, Italy. Ms. Leonardi is rated as an Elite expert by MediFind in the treatment of Vernal Keratoconjunctivitis. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Vernal Keratoconjunctivitis, and Conjunctivitis (Pink Eye).
Nobuyuki Ebihara practices practicing medicine in Urayasu, Japan. Mr. Ebihara is rated as an Elite expert by MediFind in the treatment of Vernal Keratoconjunctivitis. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Allergic Conjunctivitis, Vitrectomy, and Trabeculectomy.
Summary: The aim of the study is to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants with Moderate to Severe Vernal Keratoconjunctivitis
Summary: This study is researching 2 experimental drugs, REGN5713 and REGN5715. The study drugs will be either of these drugs given alone (either REGN5713 or REGN5715) or given together (REGN5713 and REGN5715) to reduce eye allergy signs and symptoms due to birch tree pollen allergy. The aim of the study is to see how safe and effective the study drugs are at lowering eye allergy signs and symptoms compare...